Homozygous arginine at codon 72 of p53 has no prognostic significance in cervical cancer

Tumor Biology

Volumn 21, Issue 3, 2000, Pages 135-138

  Ngan, Hextan Yuen Sheung ^a,b   Liu, Vincent Wing Sun ^a   Liu, Stephanie Si ^a   Cheng, Danny Ka Leung ^a   Ng, Tong Yow ^a   Wong, Ling Chiu ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b QUEEN MARY HOSPITAL   (Hong Kong)

Author keywords

Cervical cancer; HPV; p53 Arg 72; Prognosis

Indexed keywords

ARGININE; PROTEIN P53;

ARTICLE; FEMALE; GENE MUTATION; HOMOZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROGNOSIS; PROTEIN DEGRADATION; TUMOR SUPPRESSOR GENE; UTERINE CERVIX CANCER; WART VIRUS;

EID: 0034108193     PISSN: 10104283     EISSN: None     Source Type: Journal    
DOI: 10.1159/000030119     Document Type: Article

References (21)

1. Ngan HY, Tsao SW, Liu SS, Stanley M: Abnormal expression and mutation of p53 in cervical cancer - a study at protein, RNA and DNA levels. Genitourin Med 1997;73:54-58.
2. Werness BA, Levine AJ, Howley PM: Association of human papillomavirus types 16 and 18 E6 proteins with p53. Science 1990;248:76-79.
3. Butz K, Shahabeddin L, Geisen C, Spitkovsky D, Ullmann A, Hoppe-Seyler F: Functional p53 protein in human papillomavirus-positive cancer cells. Oncogene 1995;10:927-936.
4. Butz K, Whitaker N, Denk C, Ullmann A, Geisen C, Hoppe-Seyler F: Induction of the p53-target gene GADD45 in HPV-positive cancer cells. Oncogene 1999;18:2381-2386.
5. Storey A, Thomas M, Kalita A, Harwood C, Gardiol D, Mantovani F, Breuer J, Leigh IM, Matlashewski G, Banks L: Role of a p53 polymorphism in the development of human papillomavirus-associated cancer [see comments]. Nature 1998;393:229-234.
6. Levine AJ, Momand J, Finlay CA: The p53 tumour suppressor gene. Nature 1991;351:453-456.
7. Wu X, Levine AJ: p53 and E2F-1 cooperate to mediate apoptosis. Proc Natl Acad Sci USA 1994;91:3602-3606.
8. Lowe SW, Ruley HE, Jacks T, Housman DE: p53-dependent apoptosis modulates the cytotoxicity of anticancer agents. Cell 1993;74:957-967.
9. Lowe SW, Schmitt EM, Smith SW, Osborne BA, Jacks T: p53 is required for radiation-induced apoptosis in mouse thymocytes [see comments]. Nature 1993;362:847-849.
10. Ngan HYS, Stanley M, Liu SS, Ma HK: HPV and p53 in cervical cancer. Genitourin Med 1994;70:167-170.
11. Rosenthal AN, Ryan A, Al-Jehani R, Storey A, Harwood CA, Jacobs IJ: p53 codon 72 polymorphism and risk of cervical cancer in UK. Lancet 1998;352:871-875.
12. Ngan HY, Liu VWS, Liu SS: Risk of cervical cancer is not increased in Chinese carrying homozygous arginine at codon 72 of p53. Br J Cancer 1999;80:1828-1829.
13. Auvinen A, Isola J, Visakorpi T, Koivula T, Virtanen S, Hakama M: Overexpression of p53 and long-term survival in colon carcinoma. Br J Cancer 1994;70:293-296.
14. Quinlan DC, Davidson AG, Summers CL, Warden HE, Doshi HM: Accumulation of p53 protein correlates with a poor prognosis in human lung cancer. Cancer Res 1992;52:4828-4831.
15. Thor AD, Moore-DH II, Edgerton SM, Kawasaki ES, Reihsaus E, Lynch HT, Marcus JN, Schwartz L, Chen LC, Mayall BH: Accumulation of p53 tumor suppressor gene protein: An independent marker of prognosis in breast cancers. J Natl Cancer Inst 1992;84:845-855.
16. Bremer GL, Tieboschb AT, van-der Putten HW, de Haan J, Arends JW: p53 tumor suppressor gene protein expression in cervical cancer: Relationship to prognosis. Eur J Obstet Gynecol Reprod Biol 1995;63:55-59.
17. Kainz C, Kohlberger P, Gitsch G, Sliutz G, Breitenecker G, Reinthaller A: Mutant p53 in patients with invasive cervical cancer stages IB to IIB. Gynecol Oncol 1995;57:212-214.
18. Crawford RA, Caldwell C, Iles RK, Lowe D, Shepherd JH, Chard T: Prognostic significance of the bcl-2 apoptotic family of proteins in primary and recurrent cervical cancer. Br J Cancer 1998;78:210-214.
19. DeBritton RC, Hildesheim A, De LS, Brinton LA, Pathya P, Reeves WC: Human papillomaviruses and other influences of survival from cervical cancer in Panama. Obstet Gynecol 1993;81:19-24.
20. Higgins GD, Davy M, Roder D, Uzelin DM, Phillips GE, Burrell CJ: Increased age and mortality associated with cervical carcinomas negative for human papillomavirus RNA. Lancet 1991;338:910-913.
21. Pillai R: Oncogene expression and prognosis in cervical cancer. Cancer Lett 1991;59:171-175.